IFRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
InflaRx NV (IFRX) is not a strong buy for a beginner, long-term investor at this moment. The stock has weak financial performance, a recent downgrade from analysts, and potential dilution concerns. While hedge funds are increasing their positions, the lack of strong technical or proprietary trading signals and the absence of positive catalysts suggest holding off on investment for now.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 67.839, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level of 0.937, with key support at 0.886.
Hedge funds have significantly increased their buying activity by 425.33% over the last quarter.
Leerink downgraded the stock to Market Perform with a reduced price target of $2, citing potential dilution concerns. No recent congress trading data or significant insider activity.
In Q3 2025, revenue dropped to $23,830 (-80.75% YoY), net income fell to -$12,261,089 (-29.73% YoY), EPS declined to -0.18 (-40.00% YoY), and gross margin dropped to 98.6 (-37.83% YoY).
Leerink downgraded the stock to Market Perform from Outperform, reducing the price target from $5 to $2. Analysts highlighted positive Phase 2a trial data but expressed concerns about potential dilution due to financing needs.
